Is Pielotax FDA approved?
No. This profile records Pielotax as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE KIDNEY RESTORER
A-9 Kidney Peptide Bioregulator
Pielotax is a kidney-derived peptide bioregulator designed to support nephron function, reduce kidney inflammation, and reverse early fibrosis. It works by modulating gene expression in tubular and mesangial cells, enhancing filtration capacity, and supporting hormonal outputs like erythropoietin. Valuable for maintaining kidney health with aging or after nephrotoxic insults.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
May 8, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Pielotax as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 30 mg daily orally (with food).
Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Increases histone acetylation in kidney cells
Suppresses NF-κB to reduce kidney inflammation
Inhibits TGF-β to prevent kidney scarring
Helps maintain healthy EPO production
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.